Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ADAPTIS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve ETODOLAC

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 69
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 68
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 62
  • 0 comments

FDA approve DIFLUNISAL

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 56
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 46
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

RISING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 65
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 64
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 75
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 66
  • 0 comments

FDA approve CHOLESTYRAMINE

Comment Full text
  • Previous
  • 289
  • 290
  • 291
  • 292
  • 293
  • Next

Search

News categories

  • Technical Exchange News(14633)
  • Event(6229)
  • SEC News(388090)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(236930)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin